Dihydro Sanguinarine

CAS No. 3606-45-9

Dihydro Sanguinarine( 1314-Dihydrosanguinarine )

Catalog No. M20339 CAS No. 3606-45-9

Dihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 200 In Stock
10MG 356 In Stock
25MG 597 In Stock
50MG 836 In Stock
100MG 1125 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Dihydro Sanguinarine
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.
  • Description
    Dihydrosanguinarine is a natural compound isolated from the leaves of Macleaya microcarpaand has antifungal and anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    1314-Dihydrosanguinarine
  • Pathway
    Apoptosis
  • Target
    Caspase
  • Recptor
    Caspase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3606-45-9
  • Formula Weight
    333.34
  • Molecular Formula
    C20H15NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:5.2 mg/mL (15.60 mM)
  • SMILES
    CN1Cc2c3OCOc3ccc2-c2ccc3cc4OCOc4cc3c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Vrba JDolezel P Vicar Jetal.Cytotoxic activity of sanguinarine and dihydrosanguinarine in human promyelocytic leukemia HL-60 cells[J].Toxicol In Vitro. 2009 Jun;23(4):580-8
molnova catalog
related products
  • Z-LEHD-fmk

    Z-LEHD-FMK is a selective and potent caspase-9 inhibitor that protects against reperfusion injury and slows apoptosis. Z-LEHD-FMK exhibits antitumor and neuroprotective activity.

  • Fmoc-Val-Ala-PAB

    Fmoc-Val-Ala-PAB is a useful linker for making Antibody-Drug-Conjugation (ADC) conjugate for targeting drug delivery.

  • Emricasan

    Emricasan (IDN-6556;PF-03491390) is a potent, irreversible pan-caspase inhibitor, shows neuroprotective activity for hNPCs, inhibits ZIKV-induced increased caspase-3 activity.